Capital Wealth Alliance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Buy
243
+1
+0.4% +$1.02K 0.14% 83
2026
Q1
$223K Hold
242
0.1% 86
2025
Q4
$253K Buy
+242
New +$231K 0.11% 76
2024
Q2
Sell
-260
Closed -$203K 111
2024
Q1
$203K Buy
+260
New +$185K 0.12% 98
2020
Q1
Sell
-245
Closed -$34K 220
2019
Q4
$34K Buy
+245
New +$28.4K 0.03% 161

Other funds holding LLY

Capital Wealth Alliance's LLY Position: Q2 2026 in Review

Capital Wealth Alliance increased its Eli Lilly (LLY) stake by 0.41% in Q2 2026, buying an estimated $1.02K and bringing the position to 243 shares worth $291K. The position accounts for 0.14% of the portfolio, ranked #83.

Capital Wealth Alliance first reported a position in LLY in Q4 2019 and has held it in 5 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capital Wealth Alliance held 243 shares of Eli Lilly worth $291K as of Q2 2026.
  • Capital Wealth Alliance bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.14% of Capital Wealth Alliance's portfolio in Q2 2026, its #83 holding.
  • Capital Wealth Alliance first reported a position in Eli Lilly in Q4 2019 and has held it in 5 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Wealth Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.